A potential mechanistic role for neuroinflammation in reward processing impairments in autism spectrum disorder
- PMID: 30552950
- PMCID: PMC6401269
- DOI: 10.1016/j.biopsycho.2018.12.008
A potential mechanistic role for neuroinflammation in reward processing impairments in autism spectrum disorder
Abstract
Accumulating evidence suggests that autism spectrum disorder (ASD) may be conceptualized within a framework of reward processing impairments. The Social Motivation Theory of Autism posits that reduced motivation to interact with people and decreased pleasure derived from social interactions may derail typical social development and contribute to the emergence of core social communication deficits in ASD. Neuroinflammation may disrupt the development of mesolimbic dopaminergic systems that are critical for optimal functioning of social reward processing systems. This neuroinflammation-induced disturbance of mesolimbic dopaminergic functioning has been substantiated using maternal immune activation rodent models whose offspring show aberrant dopaminergic corticostriatal function, as well as behavioral characteristics of ASD model systems. Preclinical findings are in turn supported by clinical evidence of increased mesolimbic neuroinflammatory responses in individuals with ASD. This review summarizes evidence for reward processing deficits and neuroinflammatory impairments in ASD and examines how immune inflammatory dysregulation may impair the development of dopaminergic mesolimbic circuitry in ASD. Finally, future research directions examining neuroinflammatory effects on reward processing in ASD are proposed.
Keywords: Autism spectrum disorder; Dopamine; Neuroinflammation; Reward.
Copyright © 2018 Elsevier B.V. All rights reserved.
Figures
References
-
- Adinolfi M, Beck SE, Haddad SA, & Seller MJ (1976). Permeability of the blood-cerebrospinal fluid barrier to plasma proteins during foetal and perinatal life. Nature, 259(5539), 140–141. - PubMed
-
- Andari E, Duhamel J-R, Zalla T, Herbrecht E, Leboyer M, & Sirigu A (2010).Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proceedings of the National Academy of Sciences of the United States of America, 107(9), 4389–4394. doi:10.1073/pnas.0910249107 - DOI - PMC - PubMed
-
- Ashwood P, Enstrom A, Krakowiak P, Hertz-Picciotto I, Hansen RL, Croen LA, … Van de Water J (2008). Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. Journal of neuroimmunology, 204(1), 149–153. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
